An Israeli firm has developed a coronavirus breathalyser test that gives results in 30 seconds, billing it as a "front line" tool that can help restore a sense of normality during the pandemic. “NanoScent”, the firm making the test kits, said an extensive trial in Israel for the presence of live ...

DRDO has established a COVID-19 testing facility at the Leh based laboratory Defence Institute of High Altitude Research (DIHAR) to enhance the rate of testing to identify the Corona cases in the Union Territory of Ladakh. The testing facility will also help in keeping close watch of the infected ...

All India Institute of Medical Sciences, Nagpur in collaboration with IIT Jodhpur and Indian Institute of Information Technology, Nagpur has indigenously designed and developed a ‘smart wrist band’ for tracking & monitoring of Covid-19 positive and suspect patients. Daily Current Affairs ...

The coronavirus vaccine developed by the University of Oxford appears safe and triggers an immune response. The widely-followed trial is currently at an advanced stage, with trials in the UK, Brazil and South Africa. Daily Current Affairs Quiz 2020 Key-Points The vaccine - called ChAdOx1 ...

AIIMS New Delhi has started a video-consultation program with ICU doctors across the country called e-ICU on 8th July, 2020 in order to strengthen the Government of India’s efforts to reduce COVID-19 mortality. Daily Current Affairs Quiz 2020 Key-Points The program aims at holding ...

Indian biopharmaceutical company Biocon has secured approval from the Drugs Controller General of India (DCGI) for its plaque psoriasis drug Itolizumab  (ALZUMAb) for emergency use in Covid-19 patients. Daily Current Affairs Quiz 2020 Key-Points The drug is an anti-CD6 IgG1 ...

The fingerprick tests, which can tell within 20 minutes if a person has ever been exposed to the COVID-19 virus, were found to be 98.6% accurate in secret human trials held in June. British ministers are making plans to distribute millions of free coronavirus antibody tests after a version backed ...

An international study led by a University of Cincinnati College of Medicine researcher suggests that the anxious behaviour or depressed mood in COVID-19 patients may be a sign that the virus affects the central nervous system. These two psychological symptoms were most closely associated with a ...

BIRAC has announced that ZyCoV-D, the plasmid DNA vaccine designed and developed by Zydus and partially funded by the Department of Biotechnology, Government of India has initiated Phase I/ II clinical trials in healthy subjects, making it the first indigenously developed vaccine for COVID-19 to ...

Indian pharmaceutical company Zydus has started human studies for its potential COVID-19 vaccine, as coronavirus infections continue to surge in the world's third worst-hit nation. In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India. ZyCoV-D, its ...